KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Other Non-Current Assets (2018 - 2025)

Castle Biosciences (CSTL) has disclosed Other Non-Current Assets for 8 consecutive years, with $3.8 million as the latest value for Q4 2025.

  • Quarterly Other Non-Current Assets rose 206.92% to $3.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.8 million through Dec 2025, up 206.92% year-over-year, with the annual reading at $3.8 million for FY2025, 206.92% up from the prior year.
  • Other Non-Current Assets hit $3.8 million in Q4 2025 for Castle Biosciences, up from $1.3 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $3.8 million in Q4 2025 to a low of $792000.0 in Q1 2023.
  • Historically, Other Non-Current Assets has averaged $1.7 million across 5 years, with a median of $1.5 million in 2023.
  • Biggest five-year swings in Other Non-Current Assets: skyrocketed 719.6% in 2021 and later crashed 70.66% in 2023.
  • Year by year, Other Non-Current Assets stood at $1.7 million in 2021, then plummeted by 35.28% to $1.1 million in 2022, then increased by 29.73% to $1.4 million in 2023, then dropped by 14.72% to $1.2 million in 2024, then skyrocketed by 206.92% to $3.8 million in 2025.
  • Business Quant data shows Other Non-Current Assets for CSTL at $3.8 million in Q4 2025, $1.3 million in Q3 2025, and $1.2 million in Q2 2025.